Commentary: Tackling the Challenges of Developing Targeted Therapies for Cancer

被引：14
|
作者：
Schilsky, Richard L. [1 ]
Allen, Jeff [2 ]
Benner, Joshua [3 ]
Sigal, Ellen [2 ]
McClellan, Mark [3 ]
机构：
[1] Univ Chicago, Hematol Oncol Sect, Chicago, IL 60637 USA
[2] Friends Canc Res, Mclean, VA USA
[3] Brookings Inst, Engelberg Ctr Healthcare Reform, Washington, DC 20036 USA
来源：
ONCOLOGIST | 2010年 / 15卷 / 05期
关键词：
CELL LUNG-CANCER; RESISTANCE; GEFITINIB;
D O I：
10.1634/theoncologist.2010-0079
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：484 / 487
页数：4
相关论文
共 50 条
  • [1] Challenges and Opportunities in Developing Targeted Therapies for Triple Negative Breast Cancer
    Chapdelaine, Abygail G.
    Sun, Gongqin
    [J]. BIOMOLECULES, 2023, 13 (08)
  • [2] Targeted Therapies and Developing Precision Medicine in Gastric Cancer
    Pihlak, Rille
    Fong, Caroline
    Starling, Naureen
    [J]. CANCERS, 2023, 15 (12)
  • [3] Evolution of targeted therapies in cancer: opportunities and challenges in the clinic
    Santhosh, Sam
    Kumar, Prasanna
    Ramprasad, Vedam
    Chaudhuri, Amitabha
    [J]. FUTURE ONCOLOGY, 2015, 11 (02) : 279 - 293
  • [4] Developing Symptom Lists for People with Cancer Treated with Targeted Therapies
    Samantha C. Sodergren
    Sally J. Wheelwright
    Deborah Fitzsimmons
    Fabio Efficace
    Mirjam Sprangers
    Peter Fayers
    Amelie Harle
    Heike Schmidt
    Andrew Bottomley
    Anne-Sophie Darlington
    Charlotte Benson
    Anne Bredart
    Leopold Hentschel
    Juan Ignacio Arraras
    Georgios Ioannidis
    Michael Leahy
    Iwona Lugowska
    Ourania Nicolatou-Galitis
    Duska Petranovic
    Gudrun E Rohde
    Vasilis Vassiliou
    Colin D. Johnson
    [J]. Targeted Oncology, 2021, 16 : 95 - 107
  • [5] Developing Targeted Therapies That Exploit Aberrant Histone Ubiquitination in Cancer
    Jeusset, Lucile M-P
    McManus, Kirk J.
    [J]. CELLS, 2019, 8 (02)
  • [6] Developing Symptom Lists for People with Cancer Treated with Targeted Therapies
    Sodergren, Samantha C.
    Wheelwright, Sally J.
    Fitzsimmons, Deborah
    Efficace, Fabio
    Sprangers, Mirjam
    Fayers, Peter
    Harle, Amelie
    Schmidt, Heike
    Bottomley, Andrew
    Darlington, Anne-Sophie
    Benson, Charlotte
    Bredart, Anne
    Hentschel, Leopold
    Arraras, Juan Ignacio
    Ioannidis, Georgios
    Leahy, Michael
    Lugowska, Iwona
    Nicolatou-Galitis, Ourania
    Petranovic, Duska
    Rohde, Gudrun E.
    Vassiliou, Vasilis
    Johnson, Colin D.
    [J]. TARGETED ONCOLOGY, 2021, 16 (01) : 95 - 107
  • [7] Rational combinations of targeted cancer therapies: background, advances and challenges
    Jin, Haojie
    Wang, Liqin
    Bernards, Rene
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2023, 22 (03) : 213 - 234
  • [8] Rational combinations of targeted cancer therapies: background, advances and challenges
    Haojie Jin
    Liqin Wang
    René Bernards
    [J]. Nature Reviews Drug Discovery, 2023, 22 : 213 - 234
  • [9] Targeted Therapies in Breast Cancer: New Approaches and Old Challenges
    Witzel, Isabell
    Mueller, Volkmar
    [J]. BREAST CARE, 2015, 10 (03) : 157 - 158
  • [10] Targeted therapies in bladder cancer: signaling pathways, applications, and challenges
    Peng, Mei
    Chu, Xuetong
    Peng, Yan
    Li, Duo
    Zhang, Zhirong
    Wang, Weifan
    Zhou, Xiaochen
    Xiao, Di
    Yang, Xiaoping
    [J]. MEDCOMM, 2023, 4 (06):
12345